Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography.
PET
[68Ga]Ga-FAPI
fibroblast activation protein
radioligand therapy
theranostics
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 May 2022
25 May 2022
Historique:
received:
01
05
2022
revised:
21
05
2022
accepted:
22
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
11
6
2022
Statut:
epublish
Résumé
(1) Background: We aimed to quantitatively investigate [
Identifiants
pubmed: 35681588
pii: cancers14112609
doi: 10.3390/cancers14112609
pmc: PMC9179441
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Okayama University
ID : RECTOR
Organisme : Japan Society for the Promotion of Science
ID : 22H03027 and 21K19450
Références
J Nucl Med. 2020 Jul;61(7):951-961
pubmed: 32303601
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):870-880
pubmed: 31492994
J Nucl Med. 2020 Apr;61(4):563-569
pubmed: 31586001
Clin Nucl Med. 2011 Mar;36(3):227-8
pubmed: 21285685
Nuklearmedizin. 2018 Feb;57(1):19-25
pubmed: 29536496
Proteomics Clin Appl. 2014 Jun;8(5-6):454-63
pubmed: 24470260
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100
pubmed: 34050777
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Pharmaceuticals (Basel). 2021 Nov 24;14(12):
pubmed: 34959613
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2836-2845
pubmed: 32447444
Mol Imaging Biol. 2019 Aug;21(4):790-798
pubmed: 30406512
Oncogene. 2018 Aug;37(32):4343-4357
pubmed: 29720723
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):871-880
pubmed: 34537893
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1178-1187
pubmed: 33057927
J Nucl Med. 2018 Jan;59(1):75-81
pubmed: 28588150
Oncotarget. 2017 Jul 6;8(33):55094-55103
pubmed: 28903405
Mol Imaging Biol. 2020 Feb;22(1):190-197
pubmed: 31140110
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):50-6
pubmed: 21932117
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):61-7
pubmed: 20168287
Curr Opin Cell Biol. 2019 Feb;56:71-79
pubmed: 30308331
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
pubmed: 2402505
Genes Dev. 2016 May 1;30(9):1002-19
pubmed: 27151975
J Nucl Med. 2020 Dec;61(12):1806-1813
pubmed: 32332144
Nuklearmedizin. 2021 Oct;60(5):344-354
pubmed: 34256394
Circ Cardiovasc Imaging. 2020 Sep;13(9):e010628
pubmed: 32912030
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385
pubmed: 34137945
J Nucl Med. 2022 Mar;63(3):415-423
pubmed: 34168013
Theranostics. 2020 Jan 1;10(1):1-16
pubmed: 31903102
CA Cancer J Clin. 2016 Jul;66(4):309-25
pubmed: 26919165
J Nucl Med. 2022 Jun;63(6):890-896
pubmed: 34620730
J Nucl Med. 2007 Jun;48(6):932-45
pubmed: 17504879
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3951-3960
pubmed: 34050405
Cancer Metastasis Rev. 2020 Sep;39(3):783-803
pubmed: 32601975
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Clin Nucl Med. 2022 Jun 1;47(6):512-516
pubmed: 35439187
J Nucl Med. 2022 May;63(5):727-734
pubmed: 34385340
Theranostics. 2021 Jul 6;11(16):7984-7994
pubmed: 34335975
Mol Imaging Biol. 2022 Mar 21;:
pubmed: 35312939
Nucl Med Commun. 2022 Jul 1;43(7):847-854
pubmed: 35506283
Front Cardiovasc Med. 2021 Feb 25;8:614997
pubmed: 33718446
Front Oncol. 2021 Aug 19;11:648187
pubmed: 34490078